1. Home
  2. RTO vs MEDP Comparison

RTO vs MEDP Comparison

Compare RTO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

HOLD

Current Price

$33.56

Market Cap

15.4B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$494.07

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTO
MEDP
Founded
1925
1992
Country
United Kingdom
United States
Employees
64084
N/A
Industry
Business Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
14.9B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RTO
MEDP
Price
$33.56
$494.07
Analyst Decision
Strong Buy
Hold
Analyst Count
4
13
Target Price
$35.00
$498.25
AVG Volume (30 Days)
1.4M
271.9K
Earning Date
03-09-2026
04-22-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
20.98
EPS
N/A
15.28
Revenue
N/A
N/A
Revenue This Year
$16.98
$13.19
Revenue Next Year
$4.31
$7.75
P/E Ratio
$222.16
$32.79
Revenue Growth
N/A
N/A
52 Week Low
$21.68
$250.05
52 Week High
$34.09
$628.92

Technical Indicators

Market Signals
Indicator
RTO
MEDP
Relative Strength Index (RSI) 62.45 55.24
Support Level $30.09 $489.09
Resistance Level N/A $501.30
Average True Range (ATR) 0.63 16.54
MACD 0.26 5.43
Stochastic Oscillator 86.20 57.30

Price Performance

Historical Comparison
RTO
MEDP

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: